What are key trends in the transparency compliance landscape? And, how are life sciences manufacturers tackling growing requirements
2016 Annual Report: Top 10 Pipelines
"Bad" LDL Cholesterol, Alzheimer's Diseases, Approvals, Big Pharma, Biologics License Application (BLA), Biosimilars, Biotech, Biotech/Biopharma, Biotechnology, Bispecific CD19-directed CD3 T cell engager (BiTE) antibodies, Blockbusters, Blood Cancers, Breakthrough Designation, Breakthrough Therapy, Breakthrough Therapy Designation, Breakthrough Therapy Designation, Cells, Chimeric Antigen Receptor T Cell Therapy (CART), Cholesterol, Chronic Lymphocytic Leukemia, Clinical Trials, Collaboration, Collaborations, Collaborations, Cystic Fibrosis, Deals, Diabetes, DNA, EGFR Inhibitors, Europe, European Commission, FDA, FDA/Regulatory, February 2016, Glucagon-Like Peptide-1 (GLP-1) Analogs, Immune Response, Immune System, Immune Systems, Immunotherapies, Influenza, Inhalers, Issue Archives, Mantle Cell Lymphoma (MCL), Monoclonal Antibodies, Multiple Myeloma, NDA, Neuroscience, New Drug Application (NDA), New Molecular Entities, Non-Small Cell Lung Cancer, Oncology, Pain, Parkinson's, Parkinson's Disease, Plaque Psoriasis, Potential Blockbusters, Psoriasis, R&D, Sales, SGLT2 Inhibitors, Special Reports, Specialty Therapy, Technology, TGF-Beta Inhibitors, The New England Journal of Medicine (NEJM), Therapeutics, Top 10 Pipelines, Transforming Growth Factor-beta (TGFb), Type 1 Diabetes, Type 2 Diabetes, Vaccines, Waldenstrom’s macroglobulinemiaThe pharma industry’s R&D concentration has been shifting towards specialty therapy areas as research and development returns decline for some leaders.
The CHC’s mission is to promote and protect the benefit, for society and individual patient care, of the free flow of healthcare information.
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, […]
Survey Says: 2015 U.S. Trends in Aggregate Spend, Disclosure and Transparency
Biotech, Biotechnology, Business, Centers for Medicare and Medicaid Services (CMS), European Federation of Pharmaceutical Industries and Associations (EFPIA), Healthcare Practitioners, Manufacturers, Medical Devices, Medicare and Medicaid Services (CMS), Pharma, Trends, U.S. Sunshine LawWhat are key trends in the transparency compliance landscape?
Special Feature — Ad-Ventures in Marketing VIII
Approvals, Apps, Apps, Big Data, Business, Cloud, Contraception, CRM, Data, December 2015, Facebook, FDA, FDA/Regulatory, Healthcare, Healthcare Physicians, Healthcare Practitioners, Issue Archives, IUDs, Life Sciences, LinkedIn, Marketing & Advertising, Medical Devices, Nonprofit, Oncology, Orphan Diseases, Orphan Drugs, Pricing, Sales Forces, Social Media, Social media, Software, Technology, VenturesFor the eighth year, Med Ad News has chosen three Pharmaceutical Marketing Ventures to Watch that could change the way pharmaceutical products are marketed and sold.
Merck and Pfizer collaborate with Dako in developing an immunohistochemistry (IHC)-based companion diagnostic (CDx) in immuno-oncology September 24, 2015 05:00 PM Eastern Daylight Time DARMSTADT, Germany & […]
Closely held Intarcia Therapeutics Inc. said its implantable drug-delivery pump proved superior to Merck MRK -0.42 % & Co.’s top-selling drug Januvia in helping diabetes patients control blood sugar in […]
Electronic cigarettes are less harmful than smoking traditional cigarettes and can be effective tools to help smokers quit, according to a review published Wednesday by Public Health England, a government […]
DANVERS, Mass.–(BUSINESS WIRE)–NeuroLogica, a subsidiary of Samsung Electronics Co. Ltd, announced that the Samsung GC85A Digital Radiography (DR) system has received 510(k) FDA clearance, paving the way for its availability […]